Table 3: Recommendations* for Interrupted or Delayed ...
• This table is designed to be used together with two other summary tables - Table 1: Summary of WHO Position Papers - Recommendations for Routine Immunization; and Table 2: Summary of WHO Position Papers - Recommended Routine Immunization for Children. • Vaccines can generally be co-administered (i.e. more than one vaccine given at different
Download Table 3: Recommendations* for Interrupted or Delayed ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
The Convergence of Neurobiology and Epidemiology
theannainstitute.orgTitle: The Convergence of Neurobiology and Epidemiology: Author: rfa1 Created Date: 8/22/2007 1:47:39 PM
Vaccine Excipient Summary - Centers for Disease Control ...
www.cdc.govVaccine Excipient Summary Excipients Included in U.S. Vaccines, by Vaccine In addition to weakened or killed disease antigens (such as weakened, killed, or parts of viruses or bacteria), ... The date shown in the Date column of the table is the edition date of the PI in use in January 2021 by month and year. In some cases, only a year was ...
Summary Table Total Arrears Owed Total Prospective Amount
nysrenthelp.otda.ny.govInstructions: Fill in the Summary Table and Monthly Table below for the months being claimed for ERAP assistance. Note that a given month should only have applicable arrears or prospective amounts listed – not both. Summary Table Tenant Name Total Arrears Owed $ Address Total Prospective Amount $ Monthly Table Year Month Regular Monthly Rent
CSD Registration User Guide (Summary) Table of Contents
ocpo.treasury.gov.zaThe below table outlines the different supplier types and supplier sub-types as well as the identification number and tax reference number that must be provided per supplier type. The supplier type, supplier sub-type will be selected and identification type entered on the supplier identification section of the CSD.